Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAT Study: switch from boosted protease inhibitor to atazanavir/ritonavir in HIV/HCV coinfected adults
2008-004627-28Phase 4Completed
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Nov 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atazanavir, ritonavir, lopinavir, fosamprenavir and saquinavir in Human immunodeficiency virus infection type 1 and hepatitis C virus infection (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Proportion of patients with fasting different grade of insulin sensitivity at week 96. Started Nov 2008; status: completed.
02
Drugs
atazanavirritonavirlopinavirfosamprenavirsaquinavir
03
Conditions
Human immunodeficiency virus infection type 1hepatitis C virus infection
Beyond the preview
Go deeper on 2008-004627-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004627-28.